GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: TB-500 stopped being a problem at week 21 — 34 comments in the full submission. View in context.
1.2k
c/researchpeptides·submitted 7 months ago by u/prior_auth_pain

small win: TB-500 stopped being a problem at week 21

Questionbranch of 6 comments

Quick one. Canada here. thymosin works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 5 weeks and cost roughly what I expected. The admin was worse than the…

Read the full submission and all 34 comments →

This branch

6 comments, started 7 months ago
u/piotr_grimaldi48 points·7 months ago

Yeah, identity is the first question.

replysharereportpermalink
u/georgi_adebayo19 points·7 months ago

Yeah, identity is the first question.

Disagree on that part. 99.2% and 98.1% on the same vial is normal.

replysharereportpermalink
u/piotr_grimaldi15 points·7 months ago

supply-chain naming is a mess, ask for HPLC

replysharereportpermalink
u/old_account_20237 points·7 months ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/prior_auth_painOPappeals0 points·7 months ago

Maintenance for 3 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

replysharereportpermalink
u/rania_salinas3 points·7 months ago

The confident tone is doing a lot of work that the evidence is not.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink

← back to the whole thread

About c/researchpeptides

The wider research-peptide catalogue: thymosin fragments, GH secretagogues, melanocortin agonists, and the long tail of three-letter analogs. Focus on identity verification, handling and the state of the evidence — not on protocols, because these are not approved for human use.

29kmembers
62submissions
Mar 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/researchpeptides
c/researchpeptides rules
  1. Research use only. Handling and analysis, not administration.
  2. Name the compound precisely. "TB-500" and "Thymosin Beta-4" are not the same product.
  3. Evidence-level statements required: in vitro, rodent, or human.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/sequence_checkeru/tb500_tangentu/rui_only_rou/analog_alphabet
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →